Elutia Execs to Highlight Infection-Fighting Tech at MicroCap Showcase
Event summary
- Elutia CEO Dr. Randy Mills and CSO Dr. Michelle Williams to present at Planet MicroCap Showcase 2026 on June 17.
- Company will discuss its drug-eluting biomatrix technology for reducing post-surgical infections in breast reconstruction.
- One-on-one investor meetings scheduled for June 17–18 at the Bellagio in Las Vegas.
- Presentation begins at 2:00 pm Pacific Time on June 17, accessible via live webcast.
The big picture
Elutia's focus on reducing post-surgical infections aligns with broader industry trends toward safer implant technologies. The company's participation in the Planet MicroCap Showcase underscores its push for investor engagement amid growing demand for innovative solutions in breast reconstruction. Success here could signal stronger positioning in a competitive medical device market.
What we're watching
- Commercial Traction
- How Elutia's technology adoption will progress in implant-based breast reconstruction.
- Investor Sentiment
- Whether the presentation shifts market perception of Elutia's growth potential.
- Competitive Positioning
- The pace at which Elutia can differentiate itself in the medical device compatibility space.
Related topics